(Total Views: 456)
Posted On: 12/09/2024 8:06:35 PM
Post# of 148870
Elevated levels of CCL5 indicate poor prognosis in breast cancer [33, 34], pancreatic cancer [35], cervical cancer [34], prostate cancer, ovarian cancer [36], and gastric cancer [14, 37].
This work was supported in part by a research contract from CytoDyn Inc. (X.J.), NIH R01CA132115 (R.G.P) and a DOD Breakthrough Breast Cancer Research Program grant award (# W81XWH1810605) (R.G.P.).
https://pmc.ncbi.nlm.nih.gov/articles/PMC7825185/
This work was supported in part by a research contract from CytoDyn Inc. (X.J.), NIH R01CA132115 (R.G.P) and a DOD Breakthrough Breast Cancer Research Program grant award (# W81XWH1810605) (R.G.P.).
https://pmc.ncbi.nlm.nih.gov/articles/PMC7825185/
(5)
(0)Scroll down for more posts ▼
